Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial

by Wanshen Guo, Kai Duan, Yuntao Zhang, Zhiming Yuan, Yan-Bo Zhang, Zejun Wang, Dongyang Zhao, Huajun Zhang, Zhiqiang Xie, Xinguo Li, Cheng Peng, Wei Zhang, Yunkai Yang, Wei Chen, Xiaoxiao Gao, Wangyang You, Xue-Wei Wang, Zhengli Shi, Yanxia Wang, Xu-Qin Yang, Lianghao Zhang, Lili Huang, Qian Wang, Jia Lu, Yong-Li Yang, Jing Guo, Wei Zhou, Xin Wan, Cong Wu, Wenhui Wang, Jianhui Du, Xuanxuan Nian, Xing-Hang Li, Shihe Huang, Shuo Shen, Shengli Xia, An Pan, Xiaoming Yang
Published 2021-08-01